ISIS Neutron and Muon Source Data Journal

A biophysical study of an innovative nanoconstruct designed for theranostic against Multiple Myeloma

Abstract: This project aims to develop a new cancer treatment (theranostic) specific for Multiple myeloma (MM) which is a hematologic malignancy, normally treated with pharmacological therapy and autologous stem cell transplant. The theranostic represents an innovative approach to cancer treatment, allowing to perform a diagnosis, monitoring drug response, and targeted cancer treatment. This project develops a stimuli-responsive Nanoparticle (NP) (made of ZnO) coupled to an anticancer drug (Carfilzomib) embedded in a shell of mixed synthetic and natural lipids and which is targeted with monoclonal antibodies. Preliminary data allowed us to study the shape, size and structure of the NP, as well as an interaction between the NP and the lipidic shell, however, the lipidic shell was not well characterized. With SANS due to the use of contrast variation, we can well characterize the lipid bilayer surrounding the NP core and its interaction with a membrane.

Principal Investigator: Miss ALICE PICCININI
Local Contact: Dr James Doutch
Experimenter: Dr Guillaume Gilliard
Experimenter: Dr Valeria Rondelli

DOI: 10.5286/ISIS.E.RB2410581

ISIS Experiment Number: RB2410581

Publisher: STFC ISIS Neutron and Muon Source

Data format: RAW/Nexus
Select the data format above to find out more about it.

Data Citation

The recommended format for citing this dataset in a research publication is as:
[author], [date], [title], [publisher], [doi]

For Example:
Miss ALICE PICCININI et al; (2024): A biophysical study of an innovative nanoconstruct designed for theranostic against Multiple Myeloma, STFC ISIS Neutron and Muon Source, https://doi.org/10.5286/ISIS.E.RB2410581

Data is released under the CC-BY-4.0 license.